Elicio Therapeutics (ELTX) vs Instil Bio (TIL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Instil Bio (TIL) has outperformed Elicio Therapeutics (ELTX) over the past year, losing 68.0% versus a loss of 82.8%. Over five years, ELTX leads with a -97.9% price change compared with -98.2% for TIL. Elicio Therapeutics is the larger company by market cap ($47.6 million vs $44.5 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELTX | TIL |
|---|---|---|
| Share price | $1.81 | $6.56 |
| Market cap | $47.57M | $44.49M |
| 1-day change | -2.16% | -4.23% |
| YTD return | -77.26% | -40.36% |
| 1-year return | -82.79% | -68.05% |
| 5-year return | -97.92% | -98.17% |
| EPS (TTM) | $-2.16 | $-4.43 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $16.00 | $21.98 |
| 52-week low | $1.71 | $5.67 |
| Distance from 52-week high | -88.69% | -70.15% |
| Analyst consensus | strong_buy | none |
| Avg. price target upside | +655.25% | +6.71% |
| Average volume | 340.72K | 12.54K |
| Shares outstanding | 26.28M | 6.78M |
| Employees | 33 | 17 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TIL has outperformed ELTX by 14.7 percentage points over the past year.
About Elicio Therapeutics
ELTX stock →Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies for the treatment of cancer. Its lead product candidate, ELI-002, is a multivalent lymph node-targeted amphiphile (AMP) peptide vaccine that is in Phase II clinical trials for seven Kirsten rat sarcoma viral oncogene homolog driver mutations.
Healthcare · Biotechnology · 33 employees
About Instil Bio
TIL stock →Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need.
Healthcare · Biotechnology · 17 employees
ELTX vs TIL FAQ
Which is bigger, Elicio Therapeutics or Instil Bio?
Elicio Therapeutics (ELTX) is larger, with a market capitalization of $47.57M compared with $44.49M for Instil Bio (TIL).
Which stock has performed better over the past year, ELTX or TIL?
TIL returned -68.05% over the past 12 months, compared with -82.79% for ELTX (price return, excluding dividends). Past performance does not predict future results.
Are Elicio Therapeutics and Instil Bio in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.